About Emgality
Emgality is a Healthcare company based in Indianapolis (United States) founded in 2016, and was acquired by Royalty Pharma in April 2019. Patient healthcare services are provided to support individual well-being. Its chief executive, as recorded, is Dave Ricks. Its focus areas include Services for Healthcare Providers, Patient Engagement and Chronic Care Management. Its competitors include Evergreen Nephrology, Pathalys and AdaptX; 3 of its 3 listed competitors have raised funding.
Company details
Emgality was founded in 2016 and is headquartered in Indianapolis, United States. Patient healthcare services are offered within the broader healthcare sector, focusing on support for medical needs. Operations are managed through the domain emgality.com, with leadership provided by CEO Dave Ricks. Services emphasize patient assistance and care delivery in the United States, addressing various health requirements factually and efficiently.
- Headquarters Indianapolis, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website emgality.com
- Acquired by Royalty Pharma (Apr 2019)
- Investors
- Acquired byRoyalty Pharma
(Apr 2019)
Investors in Emgality
Emgality has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Royalty Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in marketed and late-stage biopharmaceutical companies. | 1996 | royaltypharma.com | New York, United States |
Investor details for Emgality
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Emgality
1 people are tracked at Emgality (1 in leadership).
| Name | Role | Group |
|---|---|---|
Dave Ricks | CEO | Leadership |
Complete people profiles for Emgality
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Emgality
2 dated milestones of Emgality across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Emgality is founded.
- Exit Acquired by Royalty Pharma.
Competitors of Emgality
Emgality has 3 listed competitors in our database, 3 of them funded. They include Evergreen Nephrology, Pathalys and AdaptX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evergreennephrology.com | 2021 | Nashville, United States | $130M | Chronic care management services for kidney diseases are provided. | ||
| pathalys.com | 2021 | Raleigh, United States | $105M | Biotherapeutics for chronic kidney disease are developed and provided. | ||
| adaptx.com | 2016 | Seattle, United States | $29.81M | Clinical management solutions are provided for healthcare by AdaptX. |
Detailed competitors of Emgality
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Healthcare Provider Support Services
3 companies that operate in the same segment as Emgality (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of self funded health plan | 2017 | New York, New York, United States | USD 224 M | 212 | ||
Provider of AI solutions for clinical, operational, and business outcomes | 2005 | Princeton, New Jersey, United States | USD 1.13 B | USD 465.22 M | 5,442 | |
AMN Healthcare is recognized as a leading healthcare staffing provider. | 1985 | San Diego, California, United States | USD 2.73 B | 2,970 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Emgality
Complete news archive for Emgality
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emgality
Emgality was founded in 2016.
Emgality is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Dave Ricks is the CEO of Emgality, as recorded in our data.
Emgality was founded in 2016 and is headquartered in Indianapolis, United States. Patient healthcare services are offered within the broader healthcare sector, focusing on support for medical needs. Operations are managed through the domain emgality.com, with leadership provided by CEO Dave Ricks. Services emphasize patient assistance and care delivery in the United States, addressing various health requirements factually and efficiently.
Emgality's top competitors include Evergreen Nephrology, Pathalys and AdaptX.
Emgality has 1 investor. Key investors include Royalty Pharma.
Yes. Emgality was acquired by Royalty Pharma in April 2019.